+987.9%
MRNA vs USAR
-49.3%
+1,037.2%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | USAR | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -5.9% | +19.0% | +14.1% |
| 7D | +20.6% | -21.8% | +42.4% | +25.8% |
| 30D | +27.1% | -39.9% | +67.1% | +38.4% |
| 3M | +353.4% | -52.5% | +405.9% | +411.7% |
| 6M | +446.3% | -67.9% | +514.2% | +543.2% |
| YTD | +776.2% | -31.1% | +807.3% | +762.3% |
| 1Y | +987.9% | -49.8% | +1,037.7% | +1,028.1% |
| All | +987.9% | -49.3% | +1,037.2% | +1,028.1% |
Cumulative growth
Daily Returns
Daily percentage return beside USAR.
Daily Out/Under-Performance
Portfolio return minus USAR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × USAR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded USAR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling